NEWS & EVENTS
NIBIB grantee Kullervo Hynynen has won the Focused Ultrasound Foundation's 2016 Visionary Award. Hynynen has been instrumental in the development of the first clinical system for MR-guided focused ultrasound. Read more at http://www.fusfoundation.org
A new device using shortwave infrared light could greatly improve ear infection diagnoses and drastically reduce unnecessary antibiotic prescriptions, a major cause of antibiotic resistance. Read more at MIT News.
A new biomaterial can be used to study how and when stem cells sense the mechanics of their surrounding environment. With further development, this biomaterial could be used to control when immature stem cells differentiate into more specialized cells for regenerative and tissue-engineering-based therapies. Read more at Penn Medicine News.
Ultrasound imaging is used around the world to help visualize developing babies and diagnose diseases. The next step in ultrasound technology is to image not just anatomy, but specific cells and molecules deeper in the body, such as those associated with tumors or bacteria in our gut. Now scientists say that protein engineering techniques might one day lead to colorful ultrasound images of cells deep within our bodies. Read more at Caltech News.
A new study reveals how spontaneous changes in the molecular characteristics of tumors can lead to tumors with a mixed population of cells requiring treatment with several types of therapeutic drugs. Read more at Mass General News.
Fierce Biotech reports on a nanovaccine developed by NIBIB researchers that could enhance a current cancer immunotherapy approach while reducing side effects. Read more at fiercebiotech.com.